John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.72% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
DNOW Inc
DNOW
$2.81B
| – | – |
-129,800
| Closed | -$1.27M |
|
|
DQ
2527
Daqo New Energy
DQ
$960M
| – | – |
-31,255
| Closed | -$2.23M |
|
2528
DTE Energy
DTE
$28.2B
| – | – |
-113,297
| Closed | -$14.6M |
|
2529
DexCom
DXCM
$34.8B
| – | – |
-791,520
| Closed | -$59M |
|
2530
Dycom Industries
DY
$11.5B
| – | – |
-25,421
| Closed | -$2.37M |
|
2531
eBay
EBAY
$47.5B
| – | – |
-40,300
| Closed | -$1.68M |
|
2532
Emergent Biosolutions
EBS
$265M
| – | – |
-16,706
| Closed | -$519K |
|
2533
Excelerate Energy
EE
$1.23B
| – | – |
-81,400
| Closed | -$1.62M |
|
2534
Equifax
EFX
$22.9B
| – | – |
-69,488
| Closed | -$12.7M |
|
2535
eGain
EGAN
$200M
| – | – |
-51,830
| Closed | -$505K |
|
2536
Encompass Health
EHC
$12B
| – | – |
-6,034
| Closed | -$269K |
|
2537
Edison International
EIX
$28.2B
| – | – |
-7,363
| Closed | -$466K |
|
2538
Enliven Therapeutics
ELVN
$4.48B
| – | – |
-29,784
| Closed | -$145K |
|
2539
Entegris
ENTG
$21B
| – | – |
-7,400
| Closed | -$682K |
|
2540
Evolus
EOLS
$557M
| – | – |
-31,621
| Closed | -$367K |
|
2541
Eos Energy Enterprises
EOSE
$1.25B
| – | – |
-11,300
| Closed | -$14K |
|
2542
Erasca
ERAS
$6.09B
| – | – |
-61,581
| Closed | -$343K |
|
2543
Elastic
ESTC
$8.66B
| – | – |
-192,590
| Closed | -$13M |
|
2544
EVI Industries
EVI
$189M
| – | – |
-15,736
| Closed | -$157K |
|
2545
East-West Bancorp
EWBC
$17.7B
| – | – |
-57,067
| Closed | -$3.7M |
|
2546
Exelixis
EXEL
$13.5B
| – | – |
-262,792
| Closed | -$5.47M |
|
2547
Factset
FDS
$10.9B
| – | – |
-3,625
| Closed | -$1.39M |
|
2548
Ferguson
FERG
$46.1B
| – | – |
-77,202
| Closed | -$8.55M |
|
2549
F5
FFIV
$21.6B
| – | – |
-14,662
| Closed | -$2.24M |
|
|
FITB
2550
Fifth Third Bancorp
FITB
$49.8B
| – | – |
-459,799
| Closed | -$15.4M |
|
Similar funds
John Overdeck's Q3 2022 Portfolio in Review
As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
- John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
- John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- John Overdeck opened 582 new positions and closed 600 in Q3 2022.
- John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.